Positron emission tomography
(Redirected from FDG-PET)
Positron Emission Tomography (PET) is an advanced imaging technique that involves the use of computerized radiography to examine metabolic activity within various tissues, especially the brain. It is primarily employed in clinical oncology and for neurological and cardiovascular applications. Positron Emission Tomography is a nuclear medicine functional imaging technique that produces a three-dimensional image or picture of functional processes within the body. It uses a small amount of a radioactive drug, or tracer, to show differences between healthy and diseased tissue.[1]
PET Imaging Process[edit | edit source]
The PET scan involves the injection of a short-lived radioactive substance, known as a radiotracer, which is absorbed by biologically active cells. The tracer is usually a biologically active molecule such as glucose, water, or ammonia, labelled with a positron-emitting isotope. As these positrons encounter electrons in the body, they undergo annihilation, producing pairs of gamma rays. These rays are then detected by the scanner and used to construct images of tissue function and metabolism.[2]
Applications[edit | edit source]
PET scans are widely used in the diagnosis and management of certain types of cancer, neurological conditions like Alzheimer's disease, and cardiovascular diseases. In cancer diagnosis, a PET scan can provide information about the presence and location of cancer, the stage of the disease, and the effectiveness of treatment.[3]
In the field of neuroscience, PET scans can be used to observe metabolic processes in the brain, which can help in the diagnosis of neurological disorders such as Parkinson's disease, epilepsy, and dementia.[4]
Risks and Considerations[edit | edit source]
While PET scans are generally safe, there are potential risks associated with the use of radiotracers, such as allergic reactions and exposure to radiation. However, the amount of radiation exposure from a PET scan is low and comparable to that from conventional imaging tests.[5]
Future Directions[edit | edit source]
The field of PET imaging continues to evolve with advancements in tracer chemistry, detector technology, and data analysis methods. This evolution is expected to enhance the accuracy and utility of PET scans, potentially enabling new applications in personalized medicine and drug development.[6]
See also[edit | edit source]
References[edit | edit source]
- ↑ "PET scan". 2021. Retrieved 2023-05-18.
- ↑ "Positron Emission Tomography - Computed Tomography (PET/CT)". 2021. Retrieved 2023-05-18.
- ↑ "Positron Emission Tomography (PET) Scan". 2021. Retrieved 2023-05-18.
- ↑ "Positron Emission Tomography (PET) Scan". 2021. Retrieved 2023-05-18.
- ↑ "Positron Emission Tomography (PET) Scan". 2021. Retrieved 2023-05-18.
- ↑ "The future of PET imaging". 2018. Retrieved 2023-05-18.
Positron emission tomography Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD